@article{ref1,
title="Use of venlafaxine in children and adolescents: a review of current literature",
journal="Depression and anxiety",
year="2000",
author="Weller, E. B. and Weller, R. A. and Davis, G. P.",
volume="12",
number="Suppl 1",
pages="85-89",
abstract="Pediatric psychopharmacology is hindered by the relative lack of controlled, empirical clinical trials [Shatzberg and Nemeroff, 1998: Washington, D.C.: The American Psychiatric Press, Inc. p 301-306]. Psychiatric disorders in children and adolescents carry considerable morbidity, impede development, and carry a significant mortality by suicide. Therefore, there is a need for studies of antidepressants and other psychotropics in children and adolescents. This article reviews the preliminary evidence that venlafaxine (Effexor), a novel antidepressant, may be useful in children and adolescents with a variety of psychiatric disorders.<p /><p>Language: en</p>",
language="en",
issn="1091-4269",
doi="10.1002/1520-6394(2000)12:1+<85::AID-DA12>3.0.CO;2-0",
url="http://dx.doi.org/10.1002/1520-6394(2000)12:1+<85::AID-DA12>3.0.CO;2-0"
}